UA94718C2 - N-oxides as prodrugs of piperazine&piperidine derivatives - Google Patents
N-oxides as prodrugs of piperazine&piperidine derivativesInfo
- Publication number
- UA94718C2 UA94718C2 UAA200803586A UAA200803586A UA94718C2 UA 94718 C2 UA94718 C2 UA 94718C2 UA A200803586 A UAA200803586 A UA A200803586A UA A200803586 A UAA200803586 A UA A200803586A UA 94718 C2 UA94718 C2 UA 94718C2
- Authority
- UA
- Ukraine
- Prior art keywords
- art
- relates
- disease
- manufacture
- disclosed
- Prior art date
Links
- 150000001204 N-oxides Chemical class 0.000 title abstract 2
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 239000003814 drug Substances 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 2
- 230000009286 beneficial effect Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010003805 Autism Diseases 0.000 abstract 1
- 208000020706 Autistic disease Diseases 0.000 abstract 1
- 206010012335 Dependence Diseases 0.000 abstract 1
- 208000011688 Generalised anxiety disease Diseases 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000020114 Schizophrenia and other psychotic disease Diseases 0.000 abstract 1
- 208000012886 Vertigo Diseases 0.000 abstract 1
- 230000016571 aggressive behavior Effects 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 230000019771 cognition Effects 0.000 abstract 1
- 235000019788 craving Nutrition 0.000 abstract 1
- 208000029364 generalized anxiety disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
- 150000003053 piperidines Chemical class 0.000 abstract 1
- 231100000889 vertigo Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The present invention relates to N-oxides of certain piperazine and piperidine derivatives and to methods for the preparation of these compounds. The invention also relates to the use of compounds disclosed herein for the manufacture of a medicament giving a beneficial effect. A beneficial effect is disclosed herein or apparent to a person skilled in the art from the specification and general knowledge in the art. The invention also relates to the use of a compound of the invention for the manufacture of a medicament for treating or preventing a disease or condition. More particularly, the invention relates to a new use for the treatment of a disease or condition disclosed herein or apparent to a person skilled in the art from the specification and general knowledge in the art. In embodiments of the invention specific compounds disclosed herein are used for the manufacture of a medicament useful in the treatment of CNS-disorders, in particular the treatment of anxiety disorders, including generalized anxiety disorder and panic disorder, obsessive compulsive disorder, aggression, addiction (including craving), depression, autism, vertigo, schizophrenia and other psychotic disorders, Parkinson's disease and disturbances of cognition and memory. The compounds have the general formula (1) wherein the symbols have the meanings given in the specification.(1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05107671 | 2005-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA94718C2 true UA94718C2 (en) | 2011-06-10 |
Family
ID=35502590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200803586A UA94718C2 (en) | 2005-08-22 | 2006-08-21 | N-oxides as prodrugs of piperazine&piperidine derivatives |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN101248053B (en) |
| AR (1) | AR058022A1 (en) |
| BR (1) | BRPI0614843A2 (en) |
| TW (1) | TW200738656A (en) |
| UA (1) | UA94718C2 (en) |
| ZA (1) | ZA200800741B (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE503170A (en) * | 1975-09-02 | |||
| WO1997036893A1 (en) * | 1996-03-29 | 1997-10-09 | Duphar International Research B.V. | Piperazine and piperidine compounds |
| UA71590C2 (en) * | 1998-11-13 | 2004-12-15 | Duphar Int Res | Piperazine and piperidine derivatives |
| ATE255578T1 (en) * | 2000-05-12 | 2003-12-15 | Solvay Pharm Bv | PIPERAZINE AND PIPERIDINE COMPOUNDS |
| AU2003206722B2 (en) * | 2002-01-16 | 2008-01-24 | Mercury Pharma Group Limited | Prucalopride-N-oxide |
-
2006
- 2006-08-17 AR ARP060103590 patent/AR058022A1/en not_active Application Discontinuation
- 2006-08-18 TW TW095130407A patent/TW200738656A/en unknown
- 2006-08-21 UA UAA200803586A patent/UA94718C2/en unknown
- 2006-08-21 CN CN2006800306608A patent/CN101248053B/en not_active Expired - Fee Related
- 2006-08-21 BR BRPI0614843-3A patent/BRPI0614843A2/en not_active IP Right Cessation
-
2008
- 2008-01-24 ZA ZA200800741A patent/ZA200800741B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0614843A2 (en) | 2012-12-04 |
| ZA200800741B (en) | 2009-01-28 |
| CN101248053B (en) | 2011-06-01 |
| AR058022A1 (en) | 2008-01-23 |
| HK1120261A1 (en) | 2009-03-27 |
| TW200738656A (en) | 2007-10-16 |
| CN101248053A (en) | 2008-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL188903A0 (en) | N-oxides as prodrugs of piperazine & piperidine derivatives | |
| TW200505907A (en) | Piperidine-benzenesulfonamide derivatives | |
| NO20060324L (en) | [1,8] Naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| NO20051826L (en) | Heterocyclic substituted piperazines for the treatment of schizophrenia | |
| UA83899C2 (en) | Imidazole compounds for the treatment of neurodegenerative disorders | |
| TW200738645A (en) | Use of 4-imidazole derivatives for CNS disorders | |
| ATE493407T1 (en) | 3-(HETEROARYLOXY)-2-ALKYL-1- AZABICYCLOALKYL DERIVATIVES AS ALPHA.7 NEGATIVE LIGANDS FOR THE TREATMENT OF CNS DISEASES | |
| ES2162257T3 (en) | N-AMINOALQUILDIBENZOFURANCARBOXAMIDAS AS SPECIFIC LINKS OF THE DOPAMINE RECEPTOR SUBTIPE. | |
| UA85707C2 (en) | Benzoxazines for treating respiratory tract diseases | |
| IL186777A0 (en) | (3,4-dihydro-quinazolin-2-yl) - (2-aryloxy-ethyl) - amines having an activity on the 5 - ht receptor | |
| NO20072046L (en) | Halogen-substituted benzodiazepine derivatives | |
| DE602004005502D1 (en) | COMT INHIBITORS | |
| NO20072972L (en) | Therapeutic pyrazolo [3,4-B] pyridines and indazoles | |
| GB0412314D0 (en) | Compounds | |
| MXPA05004273A (en) | Phenylalkyl and pyridylalkyl piperazine derivatives. | |
| ZA200906573B (en) | Dibenzo[1,4]oxazapine compounds | |
| UA94718C2 (en) | N-oxides as prodrugs of piperazine&piperidine derivatives | |
| UA96756C2 (en) | N-oxides of pyridylmethylpiperazine and -piperidine derivatives | |
| ATE334980T1 (en) | METHOD FOR PRODUCING 2-METHYL PIPERAZINE DERIVATIVES. | |
| IL188109A0 (en) | Chloro-substituted guanidines | |
| MXPA06000193A (en) | Imidazole derivatives iii. | |
| DE69906728D1 (en) | USE OF 4-PIPERIDINE METHANOL DERIVATIVES FOR TREATING NEURAL DEVELOPMENT DISORDERS | |
| TH91553A (en) | N-Oxides that are the probiotics of the derivatives of Piperazine and Piperidine. | |
| BRPI0514077A (en) | benzyloxy derivatives as maob inhibitors | |
| NO20065697L (en) | Piperazine derivatives of alkyloxindoles. |